Table 1. Patients and lesions characteristics.
Abbreviations: BMI = body mass index, FCT = fibrous cap thickness, TCFA = thin-capped fibroatheroma.
| Non-ruptured | Ruptured | p | |
|---|---|---|---|
| n = 10 | n = 10 | ||
| Clinical characteristics | |||
| Male sex (n, %) | 8 (80%) | 8 (80%) | 1.000 |
| Age (years) | 68 ± 7 | 70 ± 10 | 0.689 |
| Hypertension (n, %) | 10 (100%) | 9 (90%) | 0.305 |
| Hyperlipidemia (n, %) | 7 (70%) | 6 (60%) | 0.639 |
| Nicotine use (n, %) | 3 (30%) | 4 (40%) | 0.639 |
| BMI (kg/m2) | 33 ± 5 | 30 ± 7 | 0.230 |
| Total cholesterol (mg/dl) | 172 ± 43 | 165 ± 33 | 0.663 |
| LDL-c (mg/dl) | 106 ± 41 | 101 ± 32 | 0.724 |
| HDL-c (mg/dl) | 39 ± 6 | 39 ± 6 | 0.972 |
| Triglycerides (mg/dl) | 161 ± 62 | 180 ± 108 | 0.640 |
| HbA1c (%) | 6.1 ± 0.5 | 7.4 ± 1.4 | 0.026 |
| hsCRP | 5.0 ± 2.3 | 26.7 ± 46.9 | 0.175 |
| Aspirine therapy (n, %) | 10 (100%) | 9 (90%) | 0.305 |
| Statine therapy (n, %) | 6 (60%) | 6 (60%) | 1.000 |
| Lesion characteristics | |||
| Minimal FCT (µm) | 97 ± 15 | 49 ± 10 | <0.001 |
| Mean FCT (µm) | 133 ± 12 | 94 ± 17 | 0.006 |
| Maximal lipid arc (°) | 110 ± 8 | 178 ± 39 | 0.001 |
| Lipid volume arc (mm*°) | 3853 ± 1294 | 9876 ± 3088 | 0.011 |
| Presence of TCFA (n, %) | 0 (0%) | 7 (70%) | 0.003 |
| Presence of macrophages (n, %) | 4 (40%) | 6 (60%) | 0.371 |
| Presence of spotty calcifications (n, %) | 7 (70%) | 8 (80%) | 0.527 |